NewLink Genetics
E414780
UNEXPLORED
NewLink Genetics is a biopharmaceutical company known for developing immuno-oncology therapies and infectious disease vaccines, including holding rights to the rVSV-ZEBOV Ebola vaccine candidate.
Jump to:
Referenced by
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.